An Assessment of the Clinical Utility of Routine Antenatal Screening of Pregnant Women at First Clinic Attendance for Haemoglobin Genotypes, Haematocrit, ABO and Rh Blood Groups in Port Harcourt, Nigeria

Zaccheaus Awortu Jeremiah

Abstract

This prospective study was designed to provide the frequencies of the haemoglobin genotypes, ABO and Rh blood groups and their effects on the haematocrit values among pregnant women in Port Harcourt. One hundred and eighty (180) pregnant women at their first clinic attendance and in their first pregnancy (parity - 0) participated in this study. The overall frequencies obtained for ABO and Rh blood groups were: 26.67% for group A, 18.33% for B, 2.22% for AB and 52.78% for O. Rh D positive was 95.56% while Rh D negative was 4.44%. The frequencies of haemoglobin genotypes were 70.00% for HbAA, 29.44% for HbAS and 0.56% for HbSS. HbAC and SC did not occur in this study population. The mean haematocrit value was 34.64%. This was found to be independent of the ABO and Rh blood groups (P>0.05). On the other hand, haemoglobin genotypes were found to exert significant effects on the haematocrit values (F = 8.01, P = 0.0005). No significant relationship was found to exist between age and the haematocrit values. (F = 0.91, P > 0.05). Since pregnancy in sickle cell disease is associated with morbidity, proper antenatal monitoring and counselling will be necessary to prevent fatal outcomes. (Afr J Reprod Health 2005; 9[3]:112-117)

 

Keywords: Antenatal, pregnant women, Haemoglobin genotypes, ABO, Rb, blood groups, Heamatocrit 

Full Text:

PDF

References

Maine D. What's so special about maternal mortality In: Berer M and SundariRavindran TR (eds) Safe Motherhood Initiatives: Critical issues. Blackwell Science Ltd, Oxford, 2000 pp. 175 - 178.

Wong WY, Powars DR. Chang L. Hiti A, Johnson C, Overturf G. Polysaccharide encapsulated bacteria infection in sickle cell anemia: a thirty year epidemiologic experience. Am J. Hematol. 1992; 39:176 - 182.

Delozier-Banchet CD, Old JM, Engel E. Prenatal Prevention of Sickle cell by DNA analysis in two cases. J. Genet Hum. 1985; 33:171 - 178.

Sinou MT. Antenatal Screening of Sickle cell Disease. 8th Postgraduate course for Training in Reproductive Medicine and Reproductive Biology. Cameroon. (Campano A ed.) 2003.

Knowles S and Poole G. Human blood group system. In: Murphy MF and Pamphilon DH eds. Practical transfusion medicine. 1st edition: Blackwell Science Ltd. London, 2002 pp. 24 - 31.

Omu AE, Tabowei O, Okpere EE The effect of sickle cell anaemia on obstetric performance in a Nigerian Community. Trop Geogr Med., 1982; 34: 47 - 50.

Ogedengbe OK, Akinyanju OO. The haemoglobinopathies and pregnancy in Lagos. Int. J. Gynaecol Obstet. 1988; 26: 229 -

Ogedengbe OK. Akinyanju O. The pattern of sickle cell disease in pregnancy in Lagos, Nigeria. West Afr. J. Med., 1993; 12:

- 100.

Odum CU, Anorlu R.I., Dim SI, Oyekan TO, Pregnancy outcome in HbSS sickle cell disease in Lagos, Nigeria. West Afr J. Med., 2002; 21: 19 - 23.

Brown BA. Hematology: Principles and Procedures 3rd ed. Lea and Febiger, Philadelphia, 1980 pp. 71 - 208.

Judd JW. Methods in Immunohematology 2nd ed. Montgornery Scientific Publication, Durham, 1998 pp. 2 - 3.

Brecher M. (ed) Technical Manual 14th ed. American Association of Blood Banks, Bethesda MD, 2003

Pramanik KJ, Pramanik S. Distribution of ABO and Rh blood groups in Nepalese Medical Students: a report. Eastern Mediterr HealthJ. 2000; 6: 156 - 158.

Wagner FF, Kasulke D, Kerowgan M and Flegel WA. Frequencies of the Blood groups, ABO, Rhesus, D. Category VI, Kell and of clinically high frequency antigens in South West Germany. InfusionstherTransfusionmed, 1995; 22: 285 - 290.

Ukaejiofor EO, Okonkwo WC, Tagbar EN, Emeribe AO. ABO and Rhesus blood groups in a Nigerian population In: Ukaejiofor EO. Blood transfusion in the tropics. Salem pess, Nigeira. 1996; pp. 1 - 11.

Worlledge S, Ogiemudia SE, Thomas CO, Ikoku BN, Luzzato L. Blood group antigein and antibodies in Nigeria Ann Trop Med. Parasitol, 1994; 68: 249 - 264.

Contreras M, Lubenko A. Antigen in human blood, In: Hoffbrand AV, Lewis SM, Tuddenham EGD (eds). Postgraduate Haematology. 4th ed. Arnold, London, 2001 pp. 183 - 199.

Bowman JM. Maternal alloimmunization and fetal haemolytic disease. In: Reece EA, Hobbins JC, Mahoney MJ, and Petrie PH (eds). Medicine of the fetus and mother. J. B. Lippincott, Philadelphia, 1992; pp. 1152 - 1154.

Jeremiah ZA, Buseri FI. Rh antigen and phenotype frequencies and probable genotypes for the four main ethnic groups in Port Harcourt, Nigeria. Immunohematology.2003; 19:86- 88.

Nwafor A, Banigo BM. A comparison of measured and predicted haemoglobin genotype in a Nigerian population in Bonny, Rivers State, Nigeria J. Appl. Sc. Environ Manage 2001; 5: 79 - 81.

Bakare AA, Azeez MA, Agbolade JO. Gene frequencies of ABO and Rhesus blood groups and haemoglobin variants in Ogbomosho, South-West, Nigeria. Global J. Med. Sc. 2004; 3:17 - 22.

Anyaegbunam A, Morel MG, Merkatz IR Antepartum fetal surveillance tests during sickle cell crises. Am J Obstet Gynecol. 1991; 165: 1081 - 1083.

Dare FO, Makinde OO, Fasubaa OB, The Obstetric Performance of sickle cell disease patients and homozygous haemoglobin C patients in Ile Ife, NigeiraInt. J. GynaecolObstet, 1992; 37:163 - 168.

Howard RJ Management of sickling conditions in pregnancy. Br. J. Hosp. Med. 1996; 56: 7 - 10.

Refbacks

  • There are currently no refbacks.